I-MED Radiology Network acquires Radiology Group
I-MED Radiology, a significant player in the healthcare sector with an extensive footprint in Australia and New Zealand, has announced its acquisition of Radiology Group. The latter is an independent doctor partnership with operations in Greater Western Sydney and the Hunter Region. This strategic acquisition aims to augment I-MED's service offerings, particularly in enhancing PET and MRI capabilities across these regions.
The deal, whose financial details remain undisclosed, is expected to consolidate I-MED's position in the radiology market by integrating Radiology Group's clinicians into its extensive network. Currently, I-MED operates 209 clinics and provides teleradiology support to over two million patients annually, extending its services to markets in both Australia and New Zealand, as well as the United States.
I-MED's CEO, Shrey Viranna, emphasized the alignment of values and visions between the two entities, highlighting the shared belief in collaboration and digital innovation. Viranna stated that the acquisition supports the company's strategy to maintain clinical autonomy while fostering growth through a connected business model.
The acquisition is poised to intensify competition in the healthcare sector, particularly in New South Wales, where demand for advanced imaging services continues to grow. As I-MED expands its footprint, competitors in the region may face increased pressure to scale their offerings or enhance existing service capabilities. The integration of digital tools and comprehensive clinical insights will likely be key differentiators in attracting both clinician partnerships and patient volumes.
The transaction is subject to customary closing conditions and regulatory approvals. Upon completion, I-MED is expected to accelerate its expansion plans in the PET and MRI segments, thereby reinforcing its leadership in the trans-Tasman radiology market. Further steps for integration and any potential market impacts will be closely monitored as the deal progresses.
Deal timeline
This transaction is classified in Healthcare. Figures and status may change as sources update.